Last updated: 2026-10-19 16:04:20. Prices reflect the latest regular market data. Stock price data is sourced from Massive.
Oric Pharmaceuticals, Inc. (ORIC) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $12.48, with a market capitalization of $1.28B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $7.23 to $14.68. This page covers its latest market performance, valuation, price trends and company information.
$1.28B | |
$12.46 | |
$40.81 | |
$2.36 | |
$12.35 | |
171.94K | |
1.49M | |
-- | |
$14.68 | |
$7.23 | |
-- | |
-- |
Oric Pharmaceuticals, Inc. (ORIC) is currently trading at $12.48 as of 2026-10-19 16:03:00, up 1.01% ($0.13) from the previous close of $12.35
During today's regular trading session, ORIC has traded between $2.36 and $40.81, with a trading volume of 171.94K shares. The current price is near the lower end of today's range.
Over the past seven days, Oric Pharmaceuticals, Inc. (ORIC) moved from $12.03 to $12.48, representing a gain of 3.70% ($0.45).
The stock traded between $10.93 and $12.89 during the period. The latest price is near the upper end of the 7-day range, indicating moderate upward.
The average daily volume was 1.44 million shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 70.4%
ORIC is currently trading at $12.48, placing it 70.4% of the way from its 52-week low of $7.23 to its 52-week high of $14.68. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 111 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Oric Pharmaceuticals, Inc. (ORIC) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.